Following review of the data by EMA, the Marketing Authorisation for IMVANEX could be extended to include use of the vaccine for adolescents during the fourth quarter of 2024. BavarianNordic is ...
Paul Chaplin, President & CEO of BavarianNordic, said: "We applaud EMA for their expedited review and decision to recommend approval of MVA-BN for adolescents. This represents an important ...
Some results have been hidden because they may be inaccessible to you